Milestone Pharmaceuticals
Montreal, US · Quebec, Canada corporation · 1 known investors
Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.
BiotechDigital HealthHealthtechMedical Devices
Founders & leadership
EB
Ela BorensteinNamed on SEC filing
FP
Francis PlatNamed on SEC filing
YR
Yves RosconiNamed on SEC filing
SW
Scott WeinerNamed on SEC filing
MM
Martin MaguireNamed on SEC filing
PD
Philippe DouvilleNamed on SEC filing
NB
Nathalie BeauregardNamed on SEC filing
BC
Benjamin CowenNamed on SEC filing
DW
Douglas WightNamed on SEC filing
PT
Paul TruexNamed on SEC filing
Board
DL
Debra LiebertBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$90.7M disclosed across 3 rounds · 2015–2018
▶$80MraisedOct 2018 · 16 investors · PharmaceuticalsRule 506(b)
▶$80MraisedOct 2018 · 16 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Guy RousseauExecutive Officer
- Nilesh KumarDirector
- Debra LiebertDirector
- Paul TruexDirector
- Francis PlatExecutive Officer
- Joseph G. OlivetoExecutive Officer, Director
- Douglas WightExecutive Officer
- Philippe DouvilleExecutive Officer
- Marco BoorsmaDirector
- Harish PimplaskarExecutive Officer
- Lorenz MullerExecutive Officer
- Jeff NelsonExecutive Officer
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Oct 2018
- Incorporated
- Corporation, Quebec, Canada
- Federal exemptions
- 06b
▶$6.9MraisedJul 2017 · 5 investors · PharmaceuticalsRule 506(b)
▶$6.9MraisedJul 2017 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Dion MadsenDirector
- Scott WeinerDirector
- Philippe DouvilleExecutive Officer
- Guy RousseauExecutive Officer
- Nilesh KumarDirector
- Francis PlatExecutive Officer
- Paul TruexDirector
- Douglas WightExecutive Officer
- Debra LiebertDirector
- Marco BoorsmaDirector
- Martin MaguireExecutive Officer
- Yves RosconiDirector
- Joseph G. OlivetoExecutive Officer, Director
- Offering amount
- $6.9M
- Amount sold
- $6.9M
- First sale
- Jul 2017
- Incorporated
- Corporation, Quebec, Canada
- Federal exemptions
- 06b
▶$3.8MraisedJun 2015 · 3 investors · PharmaceuticalsRule 506(b)
▶$3.8MraisedJun 2015 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Debra LiebertDirector
- Ela BorensteinDirector
- Francis PlatExecutive Officer
- Yves RosconiDirector
- Scott WeinerDirector
- Martin MaguireExecutive Officer
- Philippe DouvilleExecutive Officer, Director
- Nathalie BeauregardExecutive Officer
- Benjamin CowenExecutive Officer
- Douglas WightExecutive Officer
- Paul TruexExecutive Officer, Director
- Offering amount
- $9.4M
- Amount sold
- $3.8M
- First sale
- Jun 2015
- Incorporated
- Corporation, Canada (federal Level)
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Milestone Pharmaceuticals do?
- Milestone Pharmaceuticals is a life sciences company that develops therapies for patients with cardiovascular and other diseases.
- Who are Milestone Pharmaceuticals's investors?
- Milestone Pharmaceuticals's investors include Forbion.
- How much funding has Milestone Pharmaceuticals raised?
- Milestone Pharmaceuticals has disclosed $90.7M raised across 3 rounds.
- Where is Milestone Pharmaceuticals headquartered?
- Milestone Pharmaceuticals is headquartered in Montreal, US.